[Bitauto Announces First Quarter 2020 Results [1] BEIJING, June 12, 2020 /PRNewswire/ -- Bitauto Holdings Limited ("Bitauto" or the "Company") (NYSE: BITA), a leading provider of internet content & marketing services, and transaction services for China's automotive industry, today announced its unaud]
[Bitauto Announces First Quarter 2020 Results [1] BEIJING, June 12, 2020 /PRNewswire/ -- Bitauto Holdings Limited ("Bitauto" or the "Company") (NYSE: BITA), a leading provider of internet content & marketing services, and transaction services for China's automotive industry, today announced its unaud]
[] [List of Subsidiaries Name of Subsidiary Jurisdiction of Formation SGOCO International (HK) Limited Hong Kong Beijing SGOCO Image Technology Co., Ltd. People’s Republic of China SGO Corporation. Delaware, USA Boca International Limited Hong Kong Vision Lane Limited British Virgin Islands First Asi]
[Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Beijing-June 13, 2020 — Sinovac Biotech Ltd. (“Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced positive]
[Number 1.1 Announcement with respect to Grant of Share Options Under the Share Option Scheme, dated June 12, 2020 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network]
[] [List of Subsidiaries Name of Subsidiary Jurisdiction of Formation SGOCO International (HK) Limited Hong Kong Beijing SGOCO Image Technology Co., Ltd. People’s Republic of China SGO Corporation. Delaware, USA Boca International Limited Hong Kong Vision Lane Limited British Virgin Islands First Asi]
[June 15, 2020 100 F Street, N.E. Re: TD Holdings, Inc. CIK No: 0001556266 Dear Sir or Madam: New York, New York] []
[Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Beijing-June 13, 2020 — Sinovac Biotech Ltd. (“Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced positive]
[Number 1.1 Announcement with respect to Grant of Share Options Under the Share Option Scheme, dated June 12, 2020 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network]
